LOC391358 Inhibitors

Wortmannin and LY294002 act on PI3K, a kinase that serves as a major regulatory node in several signaling pathways that can phosphorylate and thereby regulate the function of LOC391358. PD98059 and SB203580 exert their effects on the MAPK signaling pathway, another critical regulatory axis within the cell that can have ramifications for the phosphorylation and thus the activity of LOC391358. SP600125 targets the JNK pathway, which can influence transcription factors and thereby modulate the expression or activity of LOC391358. Rapamycin's inhibition of mTOR can alter the regulatory network that controls protein synthesis and other mTOR-dependent processes, which may include the modulation of LOC391358.

Cyclopamine and IWR-1 target developmental signaling pathways, such as Hedgehog and Wnt, which can have implications for the regulation of LOC391358 if it is linked to these pathways. ZM-447439's inhibition of Aurora kinases and Y-27632's inhibition of ROCK can affect cell cycle progression and cytoskeletal organization, respectively, which could alter the behavior of LOC391358 if it is involved in these processes. DAPT blocks the activity of γ-secretase, an enzyme involved in the Notch signaling pathway, which can affect proteins like LOC391358 if they are part of this pathway. Lastly, U73122 disrupts the action of phospholipase C, which can lead to changes in intracellular calcium levels and protein kinase C activity, potentially altering the activity of LOC391358 if it is regulated by these signaling molecules.